Global Onychomycosis Treatment Market Size (2024 - 2029)

Onychomycosis Treatment Market Analysis

The Global Onychomycosis Treatment Market size is estimated at USD 3.36 billion in 2024, and is expected to reach USD 4.18 billion by 2029, growing at a CAGR of 4.46% during the forecast period (2024-2029).

Clinical examination, dermoscopy, and mycological examination were recommended for all patients with suspected onychomycosis prior to the COVID-19 pandemic. Non-urgent in-patient visits are being postponed as the COVID-19 pandemic spreads, and telemedicine may be used to handle some elements of onychomycosis diagnosis and treatment. Telemedicine can be used to assess individuals with suspected onychomycosis, although it's best for those who have already had their mycological confirmation. As a result, the COVID-19 pandemic is projected to cause a short-term interruption in the market. However, the revenue growth rate is predicted to recover during the forecast period, and the global onychomycosis market is expected to increase at a double-digit rate.

Onychomycosis traditionally referred to a non-dermatophytic infection of the nail but is now used as a general term to denote any fungal nail infection (tinea unguium specifically describes a dermatophytic invasion of the nail plate). Onychomycosis is of different types, such as superficial onychomycosis, distal and lateral subungual onychomycosis, proximal subungual onychomycosis, endonyx onychomycosis, and total dystrophic onychomycosis. Only around half of nail dystrophies are caused by a fungus; hence onychomycosis accounts for one-third of fungal skin infections.

The increasing geriatric population, rising prevalence of onychomycosis, diabetic population worldwide, and growing awareness about the potential threats of onychomycosis are the key driving factors in the onychomycosis treatment market. According to an article titled, 'High prevalence of mixed infections in global onychomycosis,' published in 2020, onychomycosis is estimated to occur at a prevalence of 10% worldwide, with the infecting organism most commonly being Trichophyton rubrum. In addition, according to World Health Organization's (WHO) data in 2021, by 2030, one out of every six persons on the globe will be aged 60 years or older. The number of people aged 60 years and more is expected to rise from 1 billion in 2020 to 1.4 billion by 2050. By 2050, the global population of adults aged 60 years and above will have doubled (2.1 billion).

Onychomycosis Treatment Industry Segmentation

As per the scope of the report, onychomycosis is a fungal infection of the fingernails or toenails that may involve any component of the nail unit, including the matrix, bed, or plate. The onychomycosis treatment market is segmented by treatment type (drugs, laser therapy, and photodynamic therapy), type (distal subungual onychomycosis, white superficial onychomycosis, proximal subungual onychomycosis, and other types), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.